Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Rituximab and multiple sclerosis.
A much-needed focus on progression in multiple sclerosis.
Effects of 2-Chlorodeoxyadenosine (Cladribine) on Primary Rat Microglia.
Use of amiloride and multiple sclerosis: registry-based cohort studies.
Glatiramer Acetate administration does not reduce damage after cerebral ischemia in mice.
One calcitriol dose transiently increases Helios(+)FoxP3(+) T cells and ameliorates autoimmune demyelinating disease.
Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene.
Placebo-controlled trial of oral laquinimod for multiple sclerosis.
Breastfeeding and multiple sclerosis.
A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis
Pericytes are required for blood-brain barrier integrity during embryogenesis.
A genetic screen identifies genes essential for development of myelinated axons in zebrafish.
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.
Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.
Alemtuzumab benefits hard-to-treat MS patients
Receptos to initiate Phase 3 trial of RPC1063 in relapsing multiple sclerosis
Nephrotic Syndrome in a Multiple Sclerosis Patient Receiving Long-term Interferon Beta Therapy.
Opinion: Sex inclusion in basic research drives discovery.
Immune mechanisms of new therapeutic strategies in multiple sclerosis-A focus on alemtuzumab.
Development of interferon beta-neutralising antibodies in multiple sclerosis-a systematic review and meta-analysis.
Neuromyelitis optica: Evaluation of 871 attacks and 1153 treatment courses.
FDA approval announcement for ofatumumab
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
Gordon Research Conference on Glia Biology: Functional Interactions among Glia & Neurons
Benign multiple sclerosis: a distinct clinical entity with therapeutic implications.
Pages
« first
‹ previous
…
101
102
103
104
105
106
107
108
109
…
next ›
last »